BP1168

卡维地洛

British Pharmacopoeia (BP) Reference Standard

• 同義詞: 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, BM-14190
• 經驗公式（希爾表示法）: C₂₄H₂₆N₂O₄
• CAS號碼: 72956-09-3
• 分子量：: 406.47
• MDL號碼: MFCD00864692
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• 製造商／商標名: BP
• 應用: pharmaceutical
• 儲存溫度: 2-8°C
• SMILES 字串: OC(COC1=CC=CC2=C1C3=C(C=CC=C3)N2)CNCCOC4=CC=CC=C4OC
• InChI: 1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3
• InChI 密鑰: OGHNVEJMJSYVRP-UHFFFAOYSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Carvedilol BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Carvedilol Tablets

生化／生理作用

Cavedilol is a non-selective β-adrenergic blocker with α1 blocking activity. Carvedilol is used specifically for the treatment of heart failure and high blood pressure. It has been shown to improve left ventricular ejection fraction and may reduce mortality.

包裝

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

安全資訊

• 象形圖: GHS08,GHS09
• 訊號詞: Warning
• 危險聲明: H373,H411
• 防範說明: P260 - P273 - P314 - P391 - P501
• 危險分類: Aquatic Chronic 2 - STOT RE 2
• 標靶器官: Liver,spleen,Uterus (including cervix),Adrenal gland
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable